About Supreme Pharma
Supreme Pharma is a publicly listed company based in Toronto (Canada) founded in 2014, and was acquired by Canopy Growth in April 2021. Hybrid cannabis is cultivated in greenhouses for medicinal production. Supreme Pharma has completed 3 acquisitions, including Bayfield Strategy, BlissCo and Truverra. Supreme Pharma offers products and services including Domain Auction Platform. Its focus areas include Food and Agriculture Tech, Crop Tech, Indoor Farming and Hydroponics. Its competitors include Canopy Growth, Organigram and Cannara Biotech; 1 of its 3 listed competitors has raised funding.
Company details
Supreme Pharma was founded in 2014 and is based in Toronto, Canada. Operations are centered in the cannabis sector, where indoor cultivation under LED lights in climate-controlled environments is utilized alongside traditional greenhouse methods. Hybrid strains are grown through the 7Acres entity in modular greenhouses. Products are supplied via a B2B model to other licensed producers for medicinal purposes.
- Headquarters Toronto, Canada
- Stage Acquired
- SectorsAgriculture
- Website supreme.ca
- Social LinkedIn X
- Acquired by Canopy Growth (Apr 2021)
- Legal Name Super Lithium Corp.
- Latest Funding Round$100M (USD), Post-IPO
Sep 2018
- Investors
- Investments & AcquisitionsBayfield Strategy
& 2 more
- Acquired byCanopy Growth
(Apr 2021)
Products & Services of Supreme Pharma
Supreme Pharma offers a comprehensive portfolio of products and services, including Domain Auction Platform.
Platform for bidding on domain names
Funding Insights of Supreme Pharma
- Total Rounds 10
- Last Round Post-IPO — $100M
- First Round $525,800
(Oct 2014)
All 10 funding rounds of Supreme Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | $100M | Post-IPO | – | – | – |
| Nov 2017 | $40.25M | Post-IPO | – | – | – |
| Mar 2017 | $369,667 | Post-IPO | – | – | – |
| Jun 2016 | $2.81M | Post-IPO | – | – | – |
| May 2015 | $1.21M | Post-IPO | – | – | – |
| Jan 2015 | $116,985 | Post-IPO | – | – | – |
| Jan 2015 | $116,985 | Post-IPO | – | – | – |
| Nov 2014 | $149,117 | Post-IPO | – | – | – |
| Nov 2014 | $538,049 | Post-IPO | – | – | – |
| Oct 2014 | $525,800 | Post-IPO | – | – | – |
1 investors in total: 1 institutional.
Investors in Supreme Pharma
Supreme Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Canopy Growth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Cannabis products are provided to support consumer wellness and health. | 2013 | canopygrowth.com | Smiths Falls, Canada |
Investor details for Supreme Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of Supreme Pharma
Supreme Pharma is a publicly listed company on the CSE with ticker symbol SL in Canada, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date06 Jun 2017
- Listed onTSX-V: FIRE
- Listed entitySuper Lithium Corp.
- Exchange sectorProcess industries
- ISINCA8678881092
- Share price0.25 CAD (-50.98% on the day) · 2026-09-25
- Market capitalisation3,369,875.00 CAD
- Volume (last session)10,000
Investments & Acquisitions by Supreme Pharma
Supreme Pharma has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Bayfield Strategy, BlissCo and Truverra.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Developer of hemp and cannabis-derived medicinal products | truverra.com | London, United Kingdom | 2013 | Jul 2019 | $20M | |
Provider of crop insurance and risk management services | blissco.com | Vancouver, Canada | 2013 | May 2019 | •••• | |
Finance and accounting services are provided by Bayfield Strategy. | bayfieldstrategy.com | Toronto, Canada | 2012 | Nov 2018 | •••• |
Complete acquisition details for Supreme Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Supreme Pharma
8 dated milestones of Supreme Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Supreme Pharma is founded.
- Funding First funding round of $526K.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $100.0M.
- Acquisition Acquires Bayfield Strategy.
- Acquisition Acquires BlissCo.
- Acquisition Acquires Truverra.
- Exit Acquired by Canopy Growth.
Competitors of Supreme Pharma
Supreme Pharma has 3 listed competitors in our database, 1 of them funded. They include Canopy Growth, Organigram and Cannara Biotech.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| canopygrowth.com | 2013 | Smiths Falls, Canada | 170 | Cannabis products are provided to support consumer wellness and health. | ||
| organigram.ca | 2013 | Moncton, Canada | Provider of cannabis products, brands, and international business development investments | |||
| cannara.ca | 2018 | Montreal, Canada | $17.66M | Medicinal cannabis cultivation facility |
Detailed competitors of Supreme Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Supreme Pharma
Websites that share an audience with Supreme Pharma (supreme.ca).
Websites whose visitors overlap most with Supreme Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| singlepoint.com | 100% | 4K | #4,786,602 | View details | |
| sedar.com | 100% | View details | |||
| stockhouse.com | 100% | 1.3M | #51,794 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Supreme Pharma
Complete news archive for Supreme Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supreme Pharma
Supreme Pharma was founded in 2014.
Supreme Pharma is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Supreme Pharma was founded in 2014 and is based in Toronto, Canada. Operations are centered in the cannabis sector, where indoor cultivation under LED lights in climate-controlled environments is utilized alongside traditional greenhouse methods. Hybrid strains are grown through the 7Acres entity in modular greenhouses. Products are supplied via a B2B model to other licensed producers for medicinal purposes.
Supreme Pharma's top competitors include Canopy Growth, Organigram and Cannara Biotech.
Supreme Pharma offers Domain Auction Platform.
Yes, Supreme Pharma is publicly traded on CSE under the ticker symbol SL.
Supreme Pharma has made 3 acquisitions, including Bayfield Strategy, BlissCo, and Truverra.
Supreme Pharma has 1 investor. Key investors include Canopy Growth.
Yes. Supreme Pharma was acquired by Canopy Growth in April 2021.